Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

President-elect Donald Trump recently appointed former Paypal executive David Sacks as the White House’s first-ever czar for ...

U.S. healthcare organizations lose $1.9 million on average during each day of downtime following a ransomware attack, ...

Many digital health leaders are optimistic about the digital health sector in 2025, but still anticipate headwinds, a recent survey from Summit Health Advisors revealed. Summit Health Advisors is ...

Several healthcare provisions, including drug reforms, were left out of the government funding bill, angering some healthcare ...

Real-world data is invaluable to healthcare tech developers. This type of data reflects actual patient experiences, treatments and outcomes in diverse, real-world environments — rather than ...

While social media offers benefits, there are ample indicators that, coupled with smartphones, it poses a risk of harm to the mental health and well-being of children and adolescents. As a ...

The modern concept of “triage” dates to the Napoleonic Wars, when French battlefield surgeons developed a system for assessing the wounded and determining treatment priority to govern ...

CVS Caremark, Express Scripts and Optum Rx are fighting back. After the FTC filed a lawsuit in September, accusing the three major pharmacy benefit managers of engaging in anticompetitive rebating ...

Agitation caused by Alzheimer’s disease currently has one FDA-approved therapy, but that drug brings serious safety risks. An Axsome Therapeutics drug has mixed results from its latest slate of ...